Insiders Neuren Pharmaceuticals Limited

Equities

NEU

NZNEUE0001S8

Delayed Australian S.E. Other stock markets 11:34:09 2024-05-02 pm EDT			5-day change	1st Jan Change
19.74 ^AUD	+2.92%		+2.28%	-20.95%

Apr. 24	Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments	MT
Apr. 23	Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Argenica Therapeutics Appoints Nonexecutive Chair	Nov. 29	MT
Neuren Pharmaceuticals Appoints Joe Basile to Board of Directors	23-03-01	CI
Neuren Pharmaceuticals Appoints US-Based Medical Chief	22-07-08	MT
Neuren Pharmaceuticals Appoints Liza A. Squires as Chief Medical Officer in United States	22-07-07	CI
Neuren Pharmaceuticals Limited Appoints Jon Pilcher as Managing Director	21-06-14	CI
Neuren Pharmaceuticals Limited Appoints Lauren Frazer as Chief Financial Officer, Effective August 1, 2020	20-07-29	CI
Neuren Pharmaceuticals Limited Appoints Lauren Frazer as Company Secretary, Effective August 1, 2020	20-07-29	CI
Neuren Pharmaceuticals Limited Announces Changes to Leadership Team	20-05-26	CI
Neuren Pharmaceuticals Announces the Appointment of Jon Pilcher as Chief Executive Officer	20-05-26	CI
Larry Glass to Retire from the Neuren Pharmaceuticals Limited's Board of Directors on 31 December 2018	18-12-16	CI
Neuren Announces New Appointments to the Board of Directors	18-07-03	CI
Neuren Pharmaceuticals Announces Bruce Hancox's Retirement	17-12-29	CI
Neuren Pharmaceuticals Limited Appoints Clive Blower as Vice-President of Product Development and Technical Affairs	14-06-22	CI
Neuren Announces Management Changes	13-09-01	CI
Neuren Pharmaceuticals Limited to Appoint Jon Pilcher as Chief Financial Officer and Company Secretary, Effective August 19, 2013	13-05-24	CI
Neuren Pharmaceuticals Limited Announces the Cessation of John Douglas Wilson as Director	13-05-21	CI
Neuren Pharmaceuticals Limited Announces Cessation of Robin Lance Congreve as Director	13-05-21	CI
Neuren Pharmaceuticals Limited Appoints Richard Treagus as an Executive Chairman of the Board	13-01-30	CI
Neuren Pharmaceuticals Limited Appoints Nancy E. Jones as Senior Director of Clinical Development and Medical Affairs	13-01-08	CI
Neuren Pharmaceuticals Limited Appoints Joseph Horrigan as VP Clinical and Medical Affairs	12-08-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Neuren Pharmaceuticals Limited

Equities

NEU

NZNEUE0001S8

Insiders

Filters